Immediate Impact
70 standout
Citing Papers
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
2024 Standout
Global burden of liver disease: 2023 update
2023 Standout
Works of John Leung being referenced
Cost-effectiveness of pertuzumab combined with trastuzumab and docetaxel as a first-line treatment for HER-2 positive metastatic breast cancer
2017
Common cancer risk and statins: a population-based case–control study in a Chinese population
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| John Leung | 82 | 58 | 88 | 88 | 87 | 31 | 367 | |
| Bernard J. DuBray | 64 | 124 | 73 | 81 | 92 | 21 | 328 | |
| Heleen M. Ceha | 88 | 193 | 77 | 52 | 40 | 16 | 317 | |
| Dayssy A. Diaz | 108 | 142 | 57 | 40 | 42 | 43 | 358 | |
| Sarah Jo Stephens | 106 | 120 | 66 | 38 | 25 | 28 | 373 | |
| Vivek Pawar | 108 | 69 | 17 | 110 | 90 | 28 | 395 | |
| Sheila D. Rustgi | 84 | 89 | 14 | 96 | 49 | 34 | 383 | |
| Christina Small | 82 | 37 | 82 | 88 | 54 | 27 | 383 | |
| Fuad Ismail | 37 | 90 | 17 | 43 | 87 | 31 | 328 | |
| Marco M. E. Vogel | 170 | 94 | 88 | 36 | 12 | 32 | 401 | |
| Ragheed Al-Mufti | 54 | 87 | 28 | 28 | 37 | 28 | 359 |
All Works
Login with ORCID to disown or claim papers
Loading papers...